Latest Commercialization News

Adisyn Ltd has successfully demonstrated low-temperature deposition of an sp²-based carbon layer using Atomic Layer Deposition, a milestone independently verified and critical for semiconductor integration.

Lion Energy has struck a pivotal farm-out deal with OPIC, securing 88% funding for its 2026 Bula Karang exploration well in Indonesia’s East Seram PSC, significantly reducing its financial exposure while retaining substantial upside.

Nexsen Limited has initiated FDA engagement for its rapid Group B Streptococcus diagnostic sensor, aiming for expedited US market entry, while bolstering its leadership team and scientific credentials.

ChemX Materials Limited has completed its Deed of Company Arrangement and appointed a new board, yet remains suspended from ASX trading while relying on director-related funding. The company is focused on stabilisation and exploring future opportunities.

Estrella Resources appoints Robert Mencel as CEO, transitioning to Managing Director by mid-2026, to spearhead its limestone and manganese projects in Timor-Leste. The leadership reshuffle aims to accelerate development and operational ramp-up.

TMK Energy has achieved a fifth consecutive month of rising gas production at its Gurvantes XXXV Project in Mongolia, hitting a new daily record in December 2025. The company is now advancing plans to harness this gas for power generation, signalling a promising commercial phase ahead.

Metallium’s US subsidiary has locked in a binding multi-year supply agreement with Glencore for electronic scrap, underpinning the commercial scale-up of its innovative Flash Joule Heating technology in Texas.

Elsight has transitioned from development to production with its new Aura communications platform, delivering initial units to a leading defence contractor and expanding its U.S. presence amid a strong financial turnaround in 2025.

AdAlta Limited and its subsidiary AdCella have partnered with Shanghai Cell Therapy Group to co-develop a pioneering CAR-T cancer therapy targeting solid tumours outside China. This collaboration aims to bring a novel, armored immunotherapy with promising clinical results to global markets.

Iron Road has declined to extend Revera Energy’s option to purchase a strategic 24-hectare land parcel at Cape Hardy, marking a significant shift in their green hydrogen project partnership. Two larger land purchase options remain active, with potential buyback rights now triggered.

AVA Risk Group has locked in a strategic investment of up to A$12.6 million from US-based Hale Capital, aiming to boost its footprint in the lucrative US critical infrastructure market. The deal includes convertible notes and warrants priced at an 81% premium, alongside a new board appointment.

Sprintex Limited has confirmed a significant €15.6 million purchase order from Mest Water, ensuring timely disclosure and compliance with ASX continuous disclosure rules. The company detailed its prior communications and trading halt strategy surrounding the announcement.